NSEGeneral Updates15 Jul 2026 · 15 Jul 2026, 05:54 pm
General Updates
Medplus Health Services Limited · MEDPLUS
✦ AI Summary▼ NegativeRegulatory
MedPlus Health Services Limited has received three suspension orders for drug licenses of its subsidiary Optival Health Solutions Private Limited in the state of Karnataka, resulting in potential revenue loss of Rs 0.77 lacs, Rs 0.35 lacs, and Rs 0.47 lacs respectively.
Analysis Scores
Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment2/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
MEDPLUS_15072026175122_Intimation_Signed.pdf
View document text
MedPlus Health Services Limited
July 15, 2026
The Listing Department The Listing Department
BSE Limited N ational Stock Exchange of India Limited
Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Fort, Plot No. C/1, G Block,
Mumbai – 400001 Bandra - Kurla Complex
BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051
NSE Symbol: MEDPLUS
Dear Sir/Madam,
Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has
received three suspension orders for a Drug License of a store situated in the state of Karnataka:
Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD
POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows:
Name(s) of the Nature and details of the Date of receipt of Details of the Impact on financial
Authority action(s) taken, initiated or direction or order, violation(s)/ operation or other
order(s) passed including any interim contravention(s) activities of the
or interim orders, or committed or listed entity,
any other alleged to be quantifiable in
communication from committed monetary terms to
the authority the extent possible
Suspension of Drug License Potential Revenue
Assistant Director, for one day of store situated Loss of Rs 0.77 lacs.
Drugs Control at Sarakki JP Nagar Metro
Administration Station, Karnataka
Under Rule 65 of
Bangalore Circle-3, Suspension of Drug License Order received on Potential Revenue
Drugs and Cosmetics
Bangalore, Karnataka. for one day of store situated 14.07.2026 Loss of Rs 0.35 lacs.
Act, 1940 and Drugs
at Jaraganahalli, Karnataka
and Cosmetics Rules,
Assistant Director, Suspension of Drug License Potential Revenue
1945
Drugs Control for two days of store situated Loss of Rs 0.47 lacs.
Administration, at K C Road Chikkodi,
Belgaum Circle, Karnataka
Belgaum, Karnataka.
The same will be available on the website of the Company at www.medplusindia.com and also on the websites
of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com
respectively. Kindly take the same on records.
For MedPlus Health Services Limited
Gangadi Madhukar Reddy
Managing Director and Chief Executive Officer
DIN: 00098097
040-6724 672
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com